We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Synthetic Antioxidant Peptide Protects Mice from Lethal Levels of Radiation

By LabMedica International staff writers
Posted on 18 Aug 2016
An antioxidant peptide compound that mimics those produced by the bacterium Deinococcus radiodurans was found to effectively protect cell cultures and mice exposed to lethal levels of gamma radiation.

D. More...
radiodurans is a rather large, spherical bacterium, with a diameter of 1.5 to 3.5 microns. Four cells normally stick together, forming a tetrad. The bacteria are easily cultured and do not appear to cause disease. Colonies are smooth, convex, and pink to red in color. The cells stain Gram-positive, although its cell envelope is unusual and is reminiscent of the cell walls of Gram-negative bacteria. D. radiodurans does not form endospores and is nonmotile. It uses oxygen to derive energy from organic compounds in its environment, and is often found in habitats rich in organic materials, such as soil, feces, meat, or sewage, but has also been isolated from dried foods, room dust, medical instruments, and textiles.

D. radiodurans has a unique quality in that it can repair both single- and double-stranded DNA. When damage is apparent to the cell, it brings it into a compartmental ring-like structure, where the DNA is repaired and then is able to fuse the nucleoids from the outside of the compartment with the damaged DNA. This enables the bacterium to be extremely resistant to ionizing radiation, ultraviolet light, desiccation, and oxidizing and electrophilic agents.

Investigators at the Uniformed Services University of the Health Sciences (Bethesda, MD, USA) worked with a synthetic manganese (Mn)-2+-decapeptide complex (MDP), based on the Mn antioxidants found in D. radiodurans. MDP was previously reported to be extraordinarily radioprotective of proteins in the setting of vaccine development. The peptide-component of MDP used in this study was selected from a group of synthetic peptides screened in vitro for their ability to protect cultured human cells and purified enzymes from extreme damage caused by ionizing radiation (IR).

The investigators reported in the August 8, 2016, online edition of the journal PLOS ONE that MDP accumulated in Jurkat T-cells and protected them from 100 Gy (gray) of ionizing radiation. MDP preserved the activity of T4 DNA ligase exposed to 60,000 Gy. In vivo, MDP was nontoxic and protected B6D2F1/J (female) mice from acute radiation syndrome. All irradiated mice treated with MDP survived exposure to 9.5 Gy in comparison to untreated mice, which displayed 63% lethality after 30 days. These results showed that MDP provided early protection of white blood cells, and attenuated IR-induced damage to bone marrow and hematopoietic stem cells.

"D. radiodurans has taught us – if you want to survive radiation: protect your proteins," said contributing author Dr. Michael Daly, professor of pathology at the Uniformed Services University of the Health Sciences. "Past research has shown that Deinococcus bacteria accumulate high concentrations of manganese (a metal element similar to iron) and peptides. The secret, it seems lies in its ability to protect its proteins – the “machines” of the cell – from radiation damage. And, the unusual protein-protecting antioxidants accumulated in Deinococcus cells are readily synthesized in the laboratory. Such Deinococcus antioxidants now have been shown to be highly protective of mice exposed to lethal doses of gamma rays."

"Imagine being able to take a pill that would protect you from radiation," said Dr. Daly. "Our study is the first to demonstrate that these antioxidants are safe and can protect animals from radiation injury and death. These results open the door to all kinds of possibilities in the development of radioprotective pharmaceuticals."

Related Links:
Uniformed Services University of the Health Sciences



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.